Technical

Technical — The Cooper Companies, Inc. (COO)

The fundamentals still read as a mid-single-digit organic growth story in contact lenses and fertility. Price does not. COO closed at $64.96 on April 23, 2026 — down roughly 44% from its 2024 all-time high of $115.90, parked 11 points out of 100 on its own 52-week range, with RSI at 26 and fresh lower lows each week. The tape is telling a different story than the P&L: the market is repricing the multiple, not the cash flow.

1. Snapshot

Price (USD)

$64.96

YTD Return

-19.9

1-Year Return

-18.6

52w Position

11.3

Beta (5y)

1.11

2. The 10-year tape with 50 / 200-day SMA

Loading...

Price is below the 200-day moving average by 12.8%. The 200-day sits at $74.50; the 50-day at $74.74. The ten-year picture is unambiguous: a decade-long uptrend peaked in mid-2021 around $112, repeated a lower high near $116 in September 2024, and has since rolled over. The current leg down has retraced the entire 2019–2024 advance and returned price to levels last seen in 2017–2018.

This is a downtrend regime — not a pullback in an uptrend.

3. Relative strength vs S&P 500 and Healthcare sector

Loading...

Over three years SPY has compounded to 171, the healthcare sector ETF (XLV) to 109, and COO has given back ground to 67. The company has underperformed the broad market by 104 points and its own sector by 42 points on a rebased basis, and the gap is still widening — COO is making fresh lows while both benchmarks hold or grind higher. This is not a sector story; it is a name-specific derate.

4. Momentum — RSI and MACD histogram

Loading...
Loading...

Reference lines on RSI: 30 (oversold) and 70 (overbought). Current reading: 26.

RSI printed 26 on April 23 — deeply oversold and the lowest reading in the 18-month window save the April-2025 tariff-scare low. MACD histogram has turned negative again after a brief lift in early April and the line ($-1.85$) is well below the signal ($-1.59$). Near-term (1–3 month) momentum is bearish but extended: oversold readings this deep often produce a reflex bounce, but the structure of lower highs on every RSI peak since December says sellers are still in control. A relief rally is possible; a trend change requires RSI to reclaim and hold above 50 — it hasn't since January.

5. Volume and conviction

Loading...
Loading...
No Results

The two biggest volume spikes of the last 12 months — 5.6x average on Aug 28 (down 12.9%) and 3.9x on May 30 (down 14.6%) — were both earnings-driven liquidations, not accumulation. The late-2025 bounce on 3.8x volume was the exception, and it has since been fully retraced. The current leg lower is happening on lighter volume, which is not a positive: it argues the selling is not yet exhausted, not that buyers have stepped in.

6. Volatility regime

Loading...

Current 30-day realized vol is 25%, sitting squarely in the "normal" band (p20 = 16.7%, p80 = 30.8%). It has spiked above the stressed threshold three times in the last 12 months — each time coinciding with an earnings gap. The market is not panicking about COO in a VIX sense; it is methodically marking the stock down on each quarterly data point. That is actually a worse setup than a single crash — it means the derate is fundamental, not sentiment-driven.

7. Scorecard and stance

No Results

Stance — bearish, 3-to-6 month horizon.

Every axis except volatility is negative. The fundamentals may still support mid-single-digit growth, but the tape is telling us the market has lost faith in the multiple — six consecutive quarters of lower highs, three earnings gaps down in the last twelve months, and no sector tailwind to mask it. Oversold readings argue for a reflex bounce, but reflex bounces in confirmed downtrends typically fail at the first major moving average.

Two levels to watch:

  • Reclaim $78 — above the declining 200-day and the late-2025 consolidation high — and the bearish structure breaks. That is the level that would force a re-underwrite.
  • Lose $61.78 (the 52-week low set in early April) and the next visible support is the 2022 low near $63, and below that the 2019 shelf around $59–$60. A break of $61 on volume would open another 10–12% of downside before any real buyers show up.

Until one of those happens, this is a falling-knife chart and the fundamentals tab is carrying all the bull-case weight alone.